TSC2 and cancer: Furthermore, AMPK phosphorylates TSC2 and Raptor, and inhibits mechanistic target of rapamycin (mTOR) complex 1 (mTORC1), which is often aberrantly activated in cancer cells and therefore a promising target for cancer therapy.